Analytical Data
-
Gene name
ITGa7
- Application
-
Alternative Names
ITG-A7
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13683
-
Expression Region
Arg648~Ser952
-
Molecular Weight
37kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ITGa7, short for integrin alpha 7, is a vital receptor protein that has garnered attention in biomedical research due to its significant role in muscle development and regeneration. It is primarily expressed in skeletal muscle and plays a crucial part in the interaction between muscle cells and the extracellular matrix. Dysregulation of ITGa7 has been associated with various muscle-related disorders, including muscular dystrophies and other myopathies. Recent studies have focused on the potential of ITGa7 as a therapeutic target or biomarker for these conditions. Researchers are investigating the biochemical pathways and cellular mechanisms mediated by ITGa7, aiming to understand how its function can be harnessed to promote muscle repair and regeneration. Additionally, the study of ITGa7's interaction with other integrins and signaling molecules is essential for uncovering its broader implications in cell adhesion, migration, and overall tissue homeostasis. By exploring ITGa7 at the molecular level, scientists hope to develop novel strategies for treating muscle degenerative diseases and enhancing muscle recovery in clinical settings. The ongoing research on ITGa7 thus represents a crucial intersection of cell biology, genetics, and therapeutic development, aiming to translate fundamental discoveries into practical solutions for patients suffering from muscle-related disorders.
